Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

NCT03109730 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: ABI-H0731
DRUG: Placebo for ABI-H0731
DRUG: Entecavir
DRUG: Tenofovir Disoproxil Fumarate
DRUG: Pegasys

Sponsor

Assembly Biosciences